Position in ALNY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19,166,306
+$17,247,646 QoQ
Shares Held
57,927
+1100.6% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 51.64085832168074.ToString("F0")%
Shared 48.35914167831926.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tidal Investments LLC holds $283,741,504 across 82 Biotechnology names. ALNY ranks #3 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
92,081 | $41,117,849 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
39,652 | $30,636,720 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
57,927 | $19,166,306 | |
| 4 | EXEL |
Exelixis, Inc.
|
382,343 | $16,398,690 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
137,242 | $13,346,784 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
167,598 | $10,831,857 | |
| 7 | INSM |
INSMED Inc
|
61,776 | $10,101,611 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
129,601 | $9,624,170 |
All Filings in ALNY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,166,306 | 57,927 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,918,660 | 4,825 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,142,296 | 6,891 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,817,625 | 5,574 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,654,412 | 6,127 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,103,267 | 13,188 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,650,215 | 20,544 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $2,851,119 | 11,733 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,536,495 | 10,281 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $501,685 | 2,621 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $403,256 | 2,277 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $421,856 | 2,221 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $760,214 | 3,795 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $1,014,290 | 4,268 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $488,590 | 2,441 | Shares | Sole | 2022-11-23 | |
| 2022-06-30 | $263,696 | 1,808 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $392,385 | 2,403 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $369,853 | 2,181 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $448,234 | 2,374 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $339,209 | 2,001 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||